[ET Net News Agency, 29 August 2019] Sino Biopharmaceutical Limited (01177) said its
profit attributable to owners of the parent was RMB1.44 billion for the six months ended
30 June 2019, a year-on-year increase of 5.76%. The earnings per share were RMB11.47
cents. The board of the company has declared the payment of a quarterly dividend of HK2
cents per share for the three months ended 30 June 2019. Together with the first quarterly
dividend of HK2 cents per share paid, the total dividend of first two quarters amounted to
HK4 cents per share.
The revenue was RMB12.53 billion, a year-on-year increase of 28.81%. The gross profit
was RMB10.08 billion, a year-on-year increase of 28.07%. (RC)